Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04210115 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) |
| First Submitted : | December 20, 2019 |
| First Submitted that Met QC Criteria : | December 20, 2019 |
| First Posted : | December 24, 2019 |
| Last Update Submitted that Met QC Criteria : | January 19, 2023 |
| Last Update Posted : | January 20, 2023 |